Uterine Artery Embolization for Symptomatic Fibroids

This study has been completed.

First Received: July 19, 2006 Last Updated: February 4, 2009 History of Changes

Sponsored by:	University of Manitoba
Information provided by:	University of Manitoba
ClinicalTrials.gov Identifier:	NCT00354471

Purpose

This study will evaluate the safety, efficacy , quality of life and patient satisfaction of uterine artery embolization for the treatment of symptomatic uterine fibroids. It will provide useful information in the development od guidelines in patient selection, procedural management and subsequent follow up.

Condition	Intervention	Phase
Uterine Fibroids Menorrhagia Adenomyosis	Procedure: Uterine Artery Embolization	Phase III

Study Type:	Observational
Study Design:	Prospective
Official Title:	Short and Long Term Outcomes of Uterine Artery Embolization.

Eligibility

Ages Eligible for Study:	18 Years to 60 Years
Genders Eligible for Study:	Female

Criteria

Inclusion Criteria:

Symptoms related to the pressence of uterine fibroids serious enough to consider surgical options
Confirmation of fibroids by endovaginal and transabdominal ultrasound

Exclusion Criteria:

Pedunculated fibroids
Desire for fertility
Carcinoma of pelvic organs
Previous pelvic irradiation
Bleeding diathesis and vasculitis
History of allergiy to contrst medium

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00354471

Locations

Canada, Manitoba
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3E 3P4

Sponsors and Collaborators

University of Manitoba

Investigators

Principal Investigator:

Richard S Boroditsky, MD

University of Manitoba

More Information

Additional Information:

Canadian Association of Radiologists This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	B2000 115
Study First Received:	July 19, 2006
Last Updated:	February 4, 2009
ClinicalTrials.gov Identifier:	NCT00354471 History of Changes
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Genital Diseases, Female
Neoplasms, Connective and Soft Tissue
Myofibroma
Menstruation Disturbances
Uterine Hemorrhage
Adenomyosis

Connective Tissue Diseases
Uterine Diseases
Endometriosis
Menorrhagia
Hemorrhage
Leiomyoma

Additional relevant MeSH terms:

Neoplasms, Muscle Tissue
Myofibroma
Neoplasms by Histologic Type
Uterine Hemorrhage
Uterine Diseases
Endometriosis
Leiomyoma
Genital Diseases, Female

Neoplasms, Connective and Soft Tissue
Neoplasms
Pathologic Processes
Menstruation Disturbances
Connective Tissue Diseases
Neoplasms, Connective Tissue
Menorrhagia

ClinicalTrials.gov processed this record on September 11, 2009